Home » Topics » Regulatory » Patents

Patents
RSS

ViiV Healthcare UK discloses antiviral agents

Nov. 10, 2016

Sumitomo Dainippon Pharma patents dopamine D4 receptor agonists

Nov. 10, 2016

Shionogi presents P2X7 antagonists

Nov. 9, 2016

Takeda Pharmaceutical develops SPT inhibitors

Nov. 9, 2016

Araxes Pharma describes mutant K-RAS, H-RAS or N-RAS inhibitors

Nov. 9, 2016

FORMA Therapeutics discloses mutant IDH1 inhibitors

Nov. 9, 2016

Sentinel Oncology patents p70S6K inhibitors

Nov. 9, 2016

Guangdong Zhongsheng Pharmaceutical describes thromboxane synthase inhibitors

Nov. 8, 2016

Guangzhou Maxinovel Pharmaceuticals develops ALK tyrosine kinase receptor inhibitors

Nov. 8, 2016

H. Lundbeck patents PDE1 inhibitors

Nov. 8, 2016

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.